Mirae Asset Global Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,013
Closed -$278K 1763
2021
Q3
$278K Buy
3,013
+286
+10% +$27.5K ﹤0.01% 1627
2021
Q2
$279K Buy
2,727
+190
+7% +$19.1K ﹤0.01% 1595
2021
Q1
$248K Buy
+2,537
New +$231K ﹤0.01% 1456
2020
Q1
Sell
-3,360
Closed -$264K 1497
2019
Q4
$264K Buy
+3,360
New +$248K ﹤0.01% 1374

Other funds holding USNA

Mirae Asset Global Investments's USNA Position: Q4 2021 in Review

Mirae Asset Global Investments sold out of Usana Health Sciences (USNA) in Q4 2021, closing a stake of 3,013 shares — an estimated $278K sold.

Mirae Asset Global Investments first reported a position in USNA in Q4 2019 and held it in 4 quarters. The position peaked at $279K in Q2 2021. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2021.

  • Mirae Asset Global Investments reported no remaining Usana Health Sciences position as of Q4 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,013 Usana Health Sciences shares in Q4 2021, an estimated $278K.
  • Mirae Asset Global Investments first reported a position in Usana Health Sciences in Q4 2019 and held it in 4 quarters.
  • Mirae Asset Global Investments's Usana Health Sciences position peaked at $279K in Q2 2021.
  • 191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2021.

Based on Mirae Asset Global Investments's 13F filing for Q4 2021, filed 8 Feb 2022.